公开(公告)号：US20190022039A1

公开(公告)日：2019-01-24

申请号：US16144314

申请日：2018-09-27

Applicant: AJINOMOTO CO., INC.

Inventor： Tomohiro FUJII ,  Koji OHSUMI ,  Seiji KITAJIMA ,  Yoshiro KITAHARA

IPC: A61K31/18 ,  C07C311/21 ,  C07C321/14 ,  C07D209/20 ,  C07D295/135 ,  C07D333/20 ,  C07D307/52 ,  C07D271/06 ,  C07C311/13 ,  C07D249/12 ,  C07D213/56 ,  A61P3/04 ,  A61P3/10 ,  A61K31/405 ,  A61K31/5375 ,  A61K31/5377 ,  A61K31/381 ,  A61K31/341 ,  A61K31/4245 ,  A61K31/4196 ,  A61K31/4406 ,  A61K45/06

Abstract: Compounds represented by formula (I): wherein each symbol is as defined in the present specification, or a salt thereof are useful for the prophylaxis or treatment of diabetes and obesity, and diseases related thereto.